10 BofA U.S. options overwriting ideas
BofA Securities analysts selected 10 overwriting candidates with at least 5% premium and 6% potential upside. “Overwriting ...
Wells Fargo Remains a Buy on Dexcom (DXCM)
In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...
DexCom price target raised to $91 from $85 at Citi
Citi raised the firm’s price target on DexCom (DXCM) to $91 from $85 and keeps a Buy rating on the shares as part of a 2025 outlook for the ...
DexCom (NASDAQ:DXCM) Given New $99.00 Price Target at Canaccord Genuity Group
DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by stock analysts at Canaccord Genuity Group from $89.00 to $99.00 in a research report issued to clients and investors on Monday, ...